Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Shanghai Xuerong Bio-Technology CoSZSE:300511 +2.64%59 Piotroski F-Score is 8 as of Sep. 08, 2026, which is 60% above its 10-year median of 5.00. GuruFocus rates SZSE:300511 with a GF Score™ of 59/100 and a GF Value™ of ¥4.43 (Significantly Overvalued). The stock has 5 warning signs investors should review. Among 1,944 Consumer Packaged Goods companies, Shanghai Xuerong Bio-Technology Co ranks better than 97.63% on this metric.
Good Sign:
Piotroski F-Score is 8, indicates a very healthy situation.
The zones of discrimination were as such:
Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3
Shanghai Xuerong Bio-Technology Co has an F-score of 8. It is a good or high score, which usually indicates a very healthy situation.
The historical rank and industry rank for Shanghai Xuerong Bio-Technology Co's Piotroski F-Score or its related term are showing as below:
SZSE:300511'
s Piotroski F-Score Range Over the Past 10 Years
Min: 3 Med: 5 Max: 9
Current: 8
During the past 13 years, the highest Piotroski F-Score of Shanghai Xuerong Bio-Technology Co was 9. The lowest was 3. And the median was 5.
Shanghai Xuerong Bio-Technology Co (SZSE:300511) Piotroski F-Score Explanation
The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.
He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.
He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.
What he found was something that exceeded his most optimistic expectations.
Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.
Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).
Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.
Shanghai Xuerong Bio-Technology Co Piotroski F-Score Related Terms
Shanghai Xuerong Bio-Technology Co Piotroski F-Score Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shanghai Xuerong Bio-Technology Co Piotroski F-Score Chart
SZSE:300511 vs ADM, BG, TSN: Piotroski F-Score Comparison
For the Farm Products subindustry, Shanghai Xuerong Bio-Technology Co's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shanghai Xuerong Bio-Technology Co Piotroski F-Score vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Shanghai Xuerong Bio-Technology Co's Piotroski F-Score distribution charts can be found below:
* The bar in red indicates where Shanghai Xuerong Bio-Technology Co's Piotroski F-Score falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.
Profitability
Question 1. Return on Assets (ROA)
Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.
Score 1 if positive, 0 if negative.
Shanghai Xuerong Bio-Technology Co's current Net Income (TTM) was 150.
==> Positive ==> Score 1.
Question 2. Cash Flow Return on Assets (CFROA)
Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.
Score 1 if positive, 0 if negative.
Shanghai Xuerong Bio-Technology Co's current Cash Flow from Operations (TTM) was 499.
==> Positive ==> Score 1.
Question 3. Change in Return on Assets
Compare this year's return on assets (1) to last year's return on assets.
Shanghai Xuerong Bio-Technology Co's return on assets of this year was 0.04162775. Shanghai Xuerong Bio-Technology Co's return on assets of last year was -0.12257887.
==> This year is higher. ==> Score 1.
Question 4. Quality of Earnings (Accrual)
Compare Cash flow return on assets (2) to return on assets (1)
Shanghai Xuerong Bio-Technology Co's gearing of this year was 0.06438996. Shanghai Xuerong Bio-Technology Co's gearing of last year was 0.20348096.
==> This year is lower or equal to last year. ==> Score 1.
Question 6. Change in Working Capital (Liquidity)
Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.
Score 1 if this year's current ratio is higher, 0 if it's lower
Shanghai Xuerong Bio-Technology Co's current ratio of this year was 0.37154261. Shanghai Xuerong Bio-Technology Co's current ratio of last year was 0.30943853.
==> This year's current ratio is higher. ==> Score 1.
Question 7. Change in Shares in Issue
Compare the number of shares in issue this year, to the number in issue last year.
Score 0 if there is larger number of shares in issue this year, 1 otherwise.
Shanghai Xuerong Bio-Technology Co's number of shares in issue this year was 548.957. Shanghai Xuerong Bio-Technology Co's number of shares in issue last year was 539.747.
==> There is larger number of shares in issue this year. ==> Score 0.
Efficiency
Question 8. Change in Gross Margin
Compare this year's gross margin (Gross Profit divided by sales) to last year's.
Score 1 if this year's gross margin is higher, 0 if it's lower.
Shanghai Xuerong Bio-Technology Co's gross margin of this year was 0.19566088. Shanghai Xuerong Bio-Technology Co's gross margin of last year was 0.04431916.
==> This year's gross margin is higher. ==> Score 1.
Question 9. Change in asset turnover
Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.
Score 1 if this year's asset turnover ratio is higher, 0 if it's lower
Shanghai Xuerong Bio-Technology Co's asset turnover of this year was 0.65219331. Shanghai Xuerong Bio-Technology Co's asset turnover of last year was 0.40054375.
==> This year's asset turnover is higher. ==> Score 1.
Evaluation
Piotroski F-Score
=
Que. 1
+
Que. 2
+
Que. 3
+
Que. 4
+
Que. 5
+
Que. 6
+
Que. 7
+
Que. 8
+
Que. 9
=
1
+
1
+
1
+
1
+
1
+
1
+
0
+
1
+
1
=
8
Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3
Shanghai Xuerong Bio-Technology Co has an F-score of 8. It is a good or high score, which usually indicates a very healthy situation.
Shanghai Xuerong Bio-Technology Co (SZSE:300511) has a Piotroski F-Score of 8 as of Sep. 08, 2026. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Shanghai Xuerong Bio-Technology Co and its competitors. This is 60% above median its historical median of 5.00. Over the past decade, Shanghai Xuerong Bio-Technology Co's Piotroski F-Score has ranged from 3.00 to 9.00. According to the industry distribution chart, Shanghai Xuerong Bio-Technology Co ranks #46 out of 1944 companies in the Consumer Packaged Goods industry, placing it in the top 2.4%.
Is Shanghai Xuerong Bio-Technology Co's Piotroski F-Score too high?
Shanghai Xuerong Bio-Technology Co's current Piotroski F-Score of 8 is 60% above median its 10-year median of 5.00. Over the past 10 years, this metric has ranged from a low of 3.00 to a high of 9.00. The Consumer Packaged Goods industry median Piotroski F-Score is 5.00. Shanghai Xuerong Bio-Technology Co's value of 8 is 60% above this industry median. Based on the distribution chart, Shanghai Xuerong Bio-Technology Co ranks #46 out of 1944 companies in the Consumer Packaged Goods industry, which is in the top quartile — a strong position relative to peers. Overall, Shanghai Xuerong Bio-Technology Co has a GF Score™ of 59/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Shanghai Xuerong Bio-Technology Co's Piotroski F-Score compare to ADM and BG?
According to the Consumer Packaged Goods industry distribution chart, Shanghai Xuerong Bio-Technology Co ranks #46 out of 1944 companies for Piotroski F-Score. This places Shanghai Xuerong Bio-Technology Co in the top 2% of its industry — outperforming the majority of peers. The industry median Piotroski F-Score is 5.00. Shanghai Xuerong Bio-Technology Co's value of 8 is 60% above this benchmark. Historically, Shanghai Xuerong Bio-Technology Co's own Piotroski F-Score has ranged from 3.00 to 9.00 over the past decade. While the company's 10-year median is 5.00 vs. the industry median of 5.00, Shanghai Xuerong Bio-Technology Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Piotroski F-Score for a Consumer Packaged Goods company?
The median Piotroski F-Score among Consumer Packaged Goods companies is 5.00, based on 1,944 companies in the industry. Companies in the top quartile (top 25%) have a Piotroski F-Score significantly above this median, while those in the bottom quartile fall well below. However, Piotroski F-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Shanghai Xuerong Bio-Technology Co's current Piotroski F-Score of 8 is 60% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Piotroski F-Score mean?
A high Piotroski F-Score can signal that a stock is expensive relative to its fundamentals. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Shanghai Xuerong Bio-Technology Co and its competitors. For the Consumer Packaged Goods industry, the median Piotroski F-Score is 5.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shanghai Xuerong Bio-Technology Co's current Piotroski F-Score is 8, which is 60% above median its own 10-year median of 5.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shanghai Xuerong Bio-Technology Co stock overvalued right now?
Based on GuruFocus' analysis, Shanghai Xuerong Bio-Technology Co (SZSE:300511) is currently considered Significantly Overvalued. The stock's GF Value™ is ¥4.43, compared to a current price of ¥5.83 — trading 31.6% above its estimated fair value. The current Piotroski F-Score is 8, which is 60% above median its 10-year median of 5.00 and 60% above the Consumer Packaged Goods industry median of 5.00. Shanghai Xuerong Bio-Technology Co's overall GF Score™ is 59/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Piotroski F-Score calculated?
Piotroski F-Score is calculated from a company's financial statements. For Shanghai Xuerong Bio-Technology Co (SZSE:300511), the current Piotroski F-Score is 8 as of Sep. 08, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Shanghai Xuerong Bio-Technology Co (SZSE:300511) Overvalued in 2026?
Based on GuruFocus' analysis, Shanghai Xuerong Bio-Technology Co stock appears to be overvalued.
The current stock price of ¥5.83 is trading 31.6% above its estimated GF Value™ of ¥4.43.
GuruFocus considers Shanghai Xuerong Bio-Technology Co to be Significantly Overvalued.
Key valuation signals for SZSE:300511:
Piotroski F-Score: 8 (60% above median its 10-year median of 5.00)
GF Value™: ¥4.43 vs. price of ¥5.83 (31.6% above fair value)
Industry Position: 60% above the Consumer Packaged Goods median (#46 of 1944)
No single metric tells the full story. See the SZSE:300511 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Shanghai Xuerong Bio-Technology Co Ltd is a bio-agricultural company, engages in the research, production, and marketing of edible fungi primarily in the People's Republic of China. It offers various mushroom products, such as white enoki, white-shimeji, brown-shimeji, seafood mushroom, king crab mushroom, king oyster mushroom, pleurotus nebrodensis, agaricus bisporus, and shiitake.
59GF Score
Get the complete analysis for SZSE:300511
Piotroski F-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SZSE:300511 has been successfully added to your 
